What is NDC 52536-682?

52536-682 is the product NDC for Carisoprodol, Carisoprodol 250 mg/1 tablet, listed with the FDA by Wilshire Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Wilshire Pharmaceuticals, Inc., NDC labeler code 52536. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Carisoprodol?

46 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Carisoprodol NDC 52536-682 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)52536-682Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52536-0682Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
52536-682-10	5253606821052536068210	100 TABLET in 1 BOTTLE (52536-682-10)Marketed from Feb 15, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Carisoprodol
Generic name (nonproprietary): carisoprodol
Active ingredients: Carisoprodol — 250 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Wilshire Pharmaceuticals, Inc.NDC labeler code 52536
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205126
Marketing start: Feb 15, 2017
Marketing end: Mar 31, 2027
DEA schedule: CIV
Other FDA classes: Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers: Product ID 52536-682_292b367f-9427-b730-e063-6394a90ad340SPL ID 292b367f-9427-b730-e063-6394a90ad340SPL set ID f03a1ea6-20c1-406a-a5b6-00f1a056d9ffRxCUI 197446, 730794UNII 21925K482H
Pharmacologic class: Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452536068210 followed by a unit qualifier and the quantity

Package 52536-0682-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 13, 2024.

Indications (excerpt from the label)

Carisoprodol Tablets, USP are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Carisoprodol Tablets, USP are a muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults ( 1 ) Limitation of Use Should only be used for acute treatment periods up to two or three weeks ( 1 ) Limitation of Use Carisoprodol tablets should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [see Dosage and Adminis…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 52536-682

What is NDC 52536-682?: 52536-682 is the product NDC for Carisoprodol, Carisoprodol 250 mg/1 tablet, listed with the FDA by Wilshire Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Carisoprodol.
What is the active ingredient?: Carisoprodol.
Who is the labeler?: Wilshire Pharmaceuticals, Inc., NDC labeler code 52536. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Carisoprodol?: 46 other product NDCs are listed under this name. See all Carisoprodol NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Carisoprodol NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-397	60760-0397-90
Carisoprodol	Carisoprodol 250 mg/1	TabletOral	Westminster Pharmaceuticals, LLC	69367-419	69367-0419-01
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Westminster Pharmaceuticals, LLC	69367-420	69367-0420-0169367-0420-05
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Northwind Health Company, LLC	82868-062	82868-0062-30
carisoprodol	Carisoprodol 350 mg/1	TabletOral	REMEDYREPACK INC.	70518-3792	70518-3792-00
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0291	80425-0291-0180425-0291-0280425-0291-03
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Direct_Rx	72189-386	72189-0386-3072189-0386-7272189-0386-90
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Directrx	72189-310	72189-0310-3072189-0310-6072189-0310-72+1 more
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	REMEDYREPACK INC.	70518-2800	70518-2800-00
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Medsource Pharmaceuticals	45865-233	45865-0233-3045865-0233-60

All 47 Carisoprodol NDCs

Other NDCs under ANDA 205126

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205126
Product	Strength	Form · route	Labeler	Product NDC
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Wilshire Pharmaceuticals, Inc.	52536-688